Reference health

Is BRIEF a useful instrument in day to day care of patients with phenylketonuria?

https://doi.org/10.1016/j.ymgme.2014.12.302
CiteStamped reference-health badge
28/28 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 28 checked references that resolve
resolves10.1038/nrendo.2010.125
Phenylketonuria: a 21st century perspective
resolves10.1016/S0140-6736(10)60961-0
Phenylketonuria
resolves10.1016/j.ymgme.2009.10.016
Pathogenesis of cognitive dysfunction in phenylketonuria: Review of hypotheses☆
resolves10.1007/PL00014392
Behaviour in early treated phenylketonuria: a systematic review
resolves10.1016/j.ymgme.2007.05.006
Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis
resolves10.1023/A:1020158631102
Phenylketonuria in adulthood: A collaborative study
resolves10.1016/j.ymgme.2008.06.014
Stability of blood phenylalanine levels and IQ in children with phenylketonuria
resolves10.1016/j.ymgme.2009.10.007
Executive function in early-treated phenylketonuria: Profile and underlying mechanisms☆☆☆
resolves10.1080/87565640802101482
Twenty-Five Years of Research on Neurocognitive Outcomes in Early-Treated Phenylketonuria: Intelligence and Executive Function
resolves10.1016/j.ymgme.2011.09.036
Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: A start toward standardized outcome measurement across development
resolves10.1080/87565640701375963
Are Neuropsychological Impairments in Children with Early-Treated Phenylketonuria (PKU) Related to White Matter Abnormalities or Elevated Phenylalanine Levels?
resolves10.1016/j.ymgme.2013.03.020
White matter integrity and executive abilities in individuals with phenylketonuria
resolves10.1016/j.ymgme.2009.10.006
Screening for cognitive and social–emotional problems in individuals with PKU: Tools for use in the metabolic clinic☆
resolves10.1076/chin.8.4.231.13509
Relationships Between Cognitive and Behavioral Measures of Executive Function in Children With Brain Disease
resolves10.1037/0894-4105.17.3.458
Timing is everything: Executive functions in children exposed to elevated levels of phenylalanine.
resolves10.1111/j.1399-0004.2008.01101.x
Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria
resolves10.1007/BF02126298
Preliminary neuropsychological test results
resolves10.1207/S15326942DN2202_4
Inhibition of Prepotent Responding and Attentional Flexibility in Treated Phenylketonuria
resolves10.1023/A:1021205713674
Short‐term dietary interventions in children and adolescents with treated phenylketonuria: Effects on neuropsychological outcome of a well‐controlled population
resolves10.1016/S0028-3932(01)00078-1
Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations
resolves10.1037/0894-4105.17.3.369
Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria.
resolves10.1016/S0149-7634(02)00040-4
The neuropsychological profile of early and continuously treated phenylketonuria: orienting, vigilance, and maintenance versus manipulation-functions of working memory
resolves10.1016/j.ymgme.2013.10.011
Mental health and social functioning in early treated Phenylketonuria: The PKU-COBESO study
resolves10.1016/j.jpeds.2013.12.015
Neurocognitive Evidence for Revision of Treatment Targets and Guidelines for Phenylketonuria
resolves10.1007/s10545-010-9253-9
High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double‐blind, placebo‐controlled, crossover trial
resolves10.1016/S0140-6736(86)90837-8
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
resolves10.1038/npp.2009.115
Normal Development of Brain Circuits
resolves10.1037/0894-4105.19.5.679
Executive Functioning and Speed of Processing in Phenylketonuria.
The 5 references without a DOI — listed, not checked
no DOI — not checked20-Year national screening for phenylketonuria in The Netherlands. National Guidance Commission PKU
no DOI — not checked10.1016/j.ymgme.2014.12.302_bb0175
no DOI — not checkedAmsterdam Neuropsychological Tasks: a computer aided assessment programme
no DOI — not checked10.1016/j.ymgme.2014.12.302_bb0180
no DOI — not checked10.1016/j.ymgme.2014.12.302_bb0185
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.ymgme.2014.12.302"><img src="https://citestamp.com/citestamped/10.1016/j.ymgme.2014.12.302/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.ymgme.2014.12.302/badge.svg)](https://citestamp.com/citestamped/10.1016/j.ymgme.2014.12.302)